Court sanctions Takeda's acquisition of Shire — 3 insights

Eric Oliver - Print  |

The Royal Court of Jersey sanctioned Shire's proposed acquisition of Takeda Pharmaceuticals.

Here's what you should know:

1. Takeda will close its acquisition Jan. 8.

2. Takeda is purchasing Shire for $62 billion.

3. The acquisition will make Takeda one of the world's most indebted pharmaceutical companies.

More articles on gastroenterology:
CRH Medical acquires Anesthesia Care Associates — 4 insights
5 insights into 2019 American Academy of Ophthalmology President Dr. George Williams
$15K raised for ASC employees devastated by California wildfires — 3 insights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.